JayMac Pharmaceuticals Releases Case Study: Treating Teen Depression With EnLyte
PR Web |
Depression affects up to 11% of teens, with symptoms ranging in extremes from social isolation to self harm. There is only one drug
Parents of depressed teens need and want other alternatives. Dr.
According to
"HD was referred by her pediatrician due to suicidal thoughts. She had no major stressors or trauma, but sadness, excessive sleep, fatigue, and anhedonia that had gotten worse over the past year, as well as suicidal thoughts. This patient had been prescribed Vilazodone by her pediatrician, the dose being steadily increased, with little improvement over the course of a month. She was prescribed Enlyte once a day, to which another medication was added at her 6 week follow up. After three weeks of combination Enlyte-Escitalopram therapy, she was stable, in remission, and reporting no suicidal thoughts." Click here to download the complete case study.
Read the full story at http://www.prweb.com/releases/2014/10/prweb12258782.htm
Copyright: | (c) 2014 PRWEB.COM Newswire |
Wordcount: | 504 |
New banking rules create tough barriers for state’s growing medical pot businesses
China Passenger Car Telematics Market Size 2014, Industry Share, Growth, Trends And Forecast 2017 : Market Research Reports.Biz
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News